Showing 2644 results
- Statement /
- Media Release /Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up to 7.5 years post one-time intravenous infusionAll children (100%) in the presymptomatic intravenous…
- Media Release /Biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) approved for seven indications of reference medicine Humira®* With this approval, Sandoz adalimumab HCF biosimilar will…
- Featured News /
We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.
Pagination
- ‹ Previous page
- 1
- …
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- …
- 265
- › Next page